What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Myocardial infarction
His primary scientific interests are in Myocardial infarction, Internal medicine, Percutaneous coronary intervention, Cardiology and Surgery.
His study on Conventional PCI and Cardiogenic shock is often connected to In patient as part of broader study in Myocardial infarction.
He has researched Percutaneous coronary intervention in several fields, including Angioplasty, Heart failure, MEDLINE and Medical emergency.
His research investigates the connection between Cardiology and topics such as Confidence interval that intersect with problems in Complication.
Jens Flensted Lassen usually deals with Stenosis and limits it to topics linked to Angiography and Fractional flow reserve.
His Stent research incorporates themes from Coronary artery disease, Artery and Acute coronary syndrome.
His most cited work include:
- Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial (786 citations)
- Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). (758 citations)
- Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study (598 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Surgery.
His Hazard ratio, Coronary artery disease, Sirolimus and Mace study, which is part of a larger body of work in Internal medicine, is frequently linked to In patient, bridging the gap between disciplines.
His work focuses on many connections between Cardiology and other disciplines, such as Coronary stent, that overlap with his field of interest in Intravascular ultrasound.
His Myocardial infarction research includes elements of Electrocardiography and Thrombosis.
His biological study deals with issues like Conventional PCI, which deal with fields such as Reperfusion therapy and Intensive care medicine.
His study in Stent, Randomized controlled trial and Clinical endpoint are all subfields of Surgery.
He most often published in these fields:
- Internal medicine (54.79%)
- Cardiology (45.95%)
- Myocardial infarction (33.91%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (54.79%)
- Percutaneous coronary intervention (33.91%)
- Myocardial infarction (33.91%)
In recent papers he was focusing on the following fields of study:
Jens Flensted Lassen spends much of his time researching Internal medicine, Percutaneous coronary intervention, Myocardial infarction, Cardiology and Conventional PCI.
His Percutaneous coronary intervention research includes themes of Coronary artery disease, Radiology, Angioplasty and MEDLINE.
The concepts of his Myocardial infarction study are interwoven with issues in Stent, Clinical endpoint, Randomized controlled trial and Surgery.
As a part of the same scientific study, he usually deals with the Stent, concentrating on Confidence interval and frequently concerns with Pediatrics and Logistic regression.
His work on Sirolimus is typically connected to Biodegradable polymer as part of general Surgery study, connecting several disciplines of science.
His research on Conventional PCI also deals with topics like
- Percutaneous which connect with Ostium,
- Interquartile range which is related to area like Heart failure.
Between 2017 and 2021, his most popular works were:
- Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial (96 citations)
- Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club. (85 citations)
- Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial. (79 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
